BCA
TMO icon

Biltmore Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Biltmore Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-423
Closed -$242K – 180
2021
Q3 		$242K Hold
423
– – 0.04% 132
2021
Q2 		$213K Buy
+423
New +$200K 0.04% 120

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Biltmore Capital Advisors's TMO Position: Q4 2021 in Review

Biltmore Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 423 shares — an estimated $242K sold.

Biltmore Capital Advisors first reported a position in TMO in Q2 2021 and held it in 2 quarters. The position peaked at $242K in Q3 2021. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Biltmore Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
  • Biltmore Capital Advisors sold 423 Thermo Fisher Scientific shares in Q4 2021, an estimated $242K.
  • Biltmore Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 2 quarters.
  • Biltmore Capital Advisors's Thermo Fisher Scientific position peaked at $242K in Q3 2021.
  • 2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Biltmore Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.